Ahrensburg, Germany
Velocity Clinical Research Germany GmbH
Founded in 1999 as The Pulmonary Research Institute at the LungenClinic Ahrensburg and acquired by Velocity Clinical Research in 2024, the experienced team at Velocity’s dedicated research site in Ahrensburg conducts clinical trials across a broad variety of indications, and specializes in pulmonary diseases. By developing strong working relationships with local communities and a robust patient database, Velocity’s Ahrensburg staff provides fast, accurate patient enrollment support, even for diverse populations.
Our Ahrensburg team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Ahrensburg, Velocity will deliver the right patients, investigators, and research staff for your next research program.
Velocity Clinical Research Germany GmbH
Klaus-Groth-Strasse 2-4, 2. Etage, Ahrensburg, Germany 22926
Phone: 0049-4102-8881-0
Find a Clinical Trial in Ahrensburg
Browse current research studies in Ahrensburg on VelocityClinicalTrials.eu.
Our experienced research team in Ahrensburg
Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Ahrensburg is dedicated to conducting quality research in a professional and caring environment.
-
Medical Director, Principal Investigator
Prior to joining Velocity, Dr. Watz co-led the Pulmonary Research Institute at the LungeClinic Grosshansdorf (PRI) since 2007. Under his lead, along with his colleague, Dr. Kirsten, PRI conducted over 300 studies, as well as contributed to more than 250 publications and over 300 conferences since then. Dr. Watz is a pulmonologist and internist with experience in many pulmonology indications, including COPD, bronchial asthma, bronchiectasis and pulmonary fibrosis, sarcoidosis, lymphangioleiomyomatosis, and pulmonary hypertension in fibrosing lung diseases. -
Principal Investigator, Site Director
Prior to joining Velocity, Dr. Kirsten co-led the Pulmonary Research Institute at the LungeClinic Grosshansdorf (PRI) since 2007. Under her lead, along with her colleague, Dr. Watz, PRI conducted over 300 studies, as well as contributed to more than 250 publications and over 300 conferences since then. Dr. Kirsten is a pulmonologist and internist with experience in many pulmonology indications, including COPD, bronchial asthma, bronchiectasis and pulmonary fibrosis, sarcoidosis, lymphangioleiomyomatosis, and pulmonary hypertension in fibrosing lung diseases.
Sponsors and CROs
From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.
